FundLens
63
Pharma & HealthcareBuy

UTI Healthcare

UTI · Direct–Growth · rank #4 / 18 Smart Score ke hisaab se

Data updated

UTI Healthcare ka score 63/100 hai — 18 mein #4 Pharma & Healthcare fund (Buy). Mazbooti: 3 saal ka return (category mein 95th percentile) aur Sharpe ratio (category mein 79th percentile). Kamzori: expense ratio (category mein 17th percentile).

Trailing returns

index ke muqable: Nifty 500 (index-fund proxy)
1 saal
11.8%
+12.9% index ke muqable
3 saal
25.3%
+13.8% index ke muqable
5 saal
15.1%
+3.4% index ke muqable
Launch se
16.4%

Saal-dar-saal performance

aakhri entry = is saal ab tak
2021
20.4%
2022
-11.3%
2023
39.6%
2024
44.3%
2025
-2.2%
2026
15.7%

Risk metrics

Sharpe ratio
1.23
↑ jitna zyada, utna accha
Sortino ratio
1.99
↑ jitna zyada, utna accha
Std deviation
16.70
↓ jitna kam, utna accha
Alpha
4.98
↑ jitna zyada, utna accha
Beta
0.91
≈1 yaani market ke saath

Isi category ke aur funds

Research aur education ke liye — investment advice nahi.